艾華集團(603989.SH):“榮澤鋁箔第三期20條化成箔項目”已全部正式進入投產階段
格隆匯10月26日丨艾華集團(603989.SH)公佈,“榮澤鋁箔第三期20條化成箔項目”已於2021年10月22日全部正式進入投產階段,該項目實際投入金額為1.55億元(含税),項目所有建設資金投入均為公司全資子公司新疆榮澤自有或自籌資金。該項目目前運行狀況良好,不存在運營風險。
新疆榮澤此次投資擴產項目符合公司未來發展戰略規劃,可以充分利用西部資源優勢,擴大公司化成箔原材料的生產規模,能夠更好地保證公司原料的供應與價格可控,提高公司市場競爭能力,提高盈利水平,符合公司及全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.